Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Ohio State University Comprehensive Cancer Center

7 clinical trials · 7 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Ohio State University Comprehensive Cancer Center

RECRUITINGNCT05178498

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 9601 location
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2
RECRUITINGNCT03199651

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 35841 location
Cigarette SmokerCurrent SmokerLung Adenocarcinoma+2
RECRUITINGPhase 1 / Phase 2NCT04049539

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

This phase II trial studies the side effects and how well Vyxeos works in treating patients with intermediate and high-risk acute myeloid leukemia who have failed an initial cycle...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 282 locations
Blasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent DiseaseRefractory Acute Myeloid Leukemia
RECRUITINGNCT01408225

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have created a database of...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 50001 location
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1
RECRUITINGNCT02677961

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 15001 location
Neoplasms, Connective and Soft TissueBone Neoplasms
RECRUITINGNCT06500065

68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas

This trial studies how well 68Ga-DOTATATE digital PET/CT work in diagnosing soft tissue sarcoma. 68Ga-DOTATATE is a radiotracer that may improve image quality of PET imaging. PET...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 301 location
Soft Tissue Sarcoma
RECRUITINGPhase 2NCT06749210

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Up to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options...

Sponsor: Ohio State University Comprehensive Cancer CenterEnrolling: 1402 locations
Cancer of the BreastChemotherapy-induced Neuropathy